Elevate Your Practice While Advancing Patient Care
ABOUT OUR COMPANY
TeleDaaS is a U.S. based medical practice that provides physician approved personalized dosimetry plans to hospitals and practices treating cancer with Y90.
We're committed to making personalized dosimetry the standard of care for Y90 cancer treatments. We believe that every patient deserves the most optimized treatment plan possible, and every physician deserves the tools and support to provide it.
The Right Dose, Faster
Elevate patient care with our advanced dosimetry support, revolutionize radiotherapy for improved outcomes, and empower your team to transform healthcare with us.
Dose Matters
Clinical studies demonstrate that TeleDaaS’ personalized dosimetry delivers dramatic improvements in outcomes for liver cancer patients, when used to inform the injected dose of Y90.
When compared to standard dosimetry, TeleDaaS personalized dosimetry has been shown to result in¹:
¹Dosisphere-01 trial (10.7 months -> 24.8months, 4% -> 36%)
2.3x
Increase in median post-treatment survival
8-fold
Increase in patients who become eligible for curative surgery
Our Technology Partners
WHY TELEDAAS?
The TeleDaaS Approach
We've built our service around four core principles:
Simple
Turnkey software solution with expert dosimetry planning
Collaborative
Access to world-class physicians and consultations
Accessible
24/7 cloud-based access from anywhere
Reimbursable
Comprehensive documentation for complete billing
